TransMedics Group, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
TransMedics Group, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q2 2024.
  • TransMedics Group, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $12.2M.
  • TransMedics Group, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $3M.
  • TransMedics Group, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$25M, a 30.9% increase from 2022.
  • TransMedics Group, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$36.2M, a 18.1% increase from 2021.
  • TransMedics Group, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$44.2M, a 53.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $3M $12.2M +$13.2M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$10.2M $12.2M +$14.8M Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-01
Q4 2023 -$25M $4.03M +$10.8M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$35.8M -$25.4M -$18M -242% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$17.8M -$1M +$10.5M +91.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$28.3M -$2.64M +$7.93M +75% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-01
Q4 2022 -$36.2M -$6.72M +$5.95M +47% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$42.2M -$7.43M +$5.54M +42.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$47.7M -$11.5M -$855K -8.02% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$46.9M -$10.6M -$2.65M -33.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$44.2M -$12.7M -$6.36M -101% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$37.9M -$13M -$7.87M -155% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$30M -$10.7M -$2.17M -25.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-04
Q1 2021 -$27.8M -$7.92M +$935K +10.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-04
Q4 2020 -$28.7M -$6.31M +$2.87M +31.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$31.6M -$5.09M +$3.19M +38.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$34.8M -$8.5M +$698K +7.59% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$35.5M -$8.85M -$1.96M -28.4% Jan 1, 2020 Mar 31, 2020 10-K 2021-03-11
Q4 2019 -$33.5M -$9.18M -$1.54M -20.2% Sep 29, 2019 Dec 28, 2019 10-K 2021-03-11
Q3 2019 -$32M -$8.28M -$3.18M -62.2% Jun 30, 2019 Sep 28, 2019 10-K 2021-03-11
Q2 2019 -$28.8M -$9.2M -$3.08M -50.4% Mar 30, 2019 Jun 29, 2019 10-Q 2019-08-08
Q1 2019 -$25.8M -$6.9M -$1.99M -40.7% Dec 30, 2018 Mar 30, 2019 10-K 2021-03-11
Q4 2018 -$23.8M -$7.64M Sep 30, 2018 Dec 29, 2018 10-K 2020-03-17
Q3 2018 -$5.11M Jul 1, 2018 Sep 29, 2018 10-K 2020-03-17
Q2 2018 -$6.12M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-17
Q1 2018 -$4.9M Dec 31, 2017 Mar 31, 2018 10-K 2020-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.